Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more

Luminex Corporation Receives FDA Clearance for ARIES Bordetella Assay

AUSTIN, Texas, May 3, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that it has received FDA clearance for the ARIES®Bordetella Assay for direct detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acid in nasopharyngeal swab specimens obtained from individuals suspected of having a respiratory tract infection attributable to... Read more

Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

AUSTIN, Texas, April 26, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3, 2017 at 10:00am ET in Boston, Massachusetts. The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log on to... Read more

Luminex Corporation To Present At The Deutsche Bank 42nd Annual Health Care Conference

AUSTIN, Texas, April 26, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Deutsche Bank 42nd Annual Health Care Conference on Wednesday, May 3, 2017 at 10:00am ET in Boston, Massachusetts. The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log on to... Read more

Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

AUSTIN, Texas, April 20, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16 at 1:40pm PT in Las Vegas. The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log... Read more

Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference

AUSTIN, Texas, April 20, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) announced today that management will present at the Bank of America Merrill Lynch 2017 Health Care Conference on Tuesday, May 16 at 1:40pm PT in Las Vegas. The investor presentation will be webcast live and may be accessed at Luminex Corporation’s website at http://www.luminexcorp.com. Simply log... Read more

Luminex Corporation To Present At The Barclays Global Healthcare Conference

AUSTIN, Texas, March 1, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the Barclays Global Healthcare Conference to be held at the Loews Miami Beach Hotel March 14 – 16, 2017, in Miami Beach, FL. The investor presentation will begin at 4:20 p.m. Eastern time on Wednesday, March 15,... Read more

Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

AUSTIN, Texas, Feb. 6, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full year 2016 ended December 31, 2016.  Financial and operating highlights include the following: Consolidated fourth quarter and full year 2016 revenue of $72.3 million and $270.6 million, an increase of 20% and 14% compared to the... Read more

Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results

AUSTIN, Texas, Feb. 6, 2017 /PRNewswire/ — Luminex Corporation (NASDAQ:LMNX) today announced financial results for the fourth quarter and full year 2016 ended December 31, 2016.  Financial and operating highlights include the following: Consolidated fourth quarter and full year 2016 revenue of $72.3 million and $270.6 million, an increase of 20% and 14% compared to the... Read more